Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study

被引：0
|
作者：
Annmarie Butare [1 ]
Tia Sutton [1 ]
Elizabeth Kantzler [1 ]
Katie N. Kennedy [2 ]
Dmitry Tumin [3 ]
Michael D. Honaker [4 ]
机构：
[1] Carolina University,Department of Surgery, Brody School of Medicine at East
[2] Brody School of Medicine at East Carolina University,Department of Hematology and Oncology
[3] East Carolina University Brody School of Medicine,Department of Academic Affairs
[4] East Carolina University,Department of Surgery, Division of Surgical Oncology, Division of Surgical Oncology
来源：
Journal of Gastrointestinal Cancer | 2025年 / 56卷 / 1期
关键词：
Adjuvant chemotherapy; Stage II colon cancer; High risk;
D O I：
10.1007/s12029-025-01186-z
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Adjuvant chemotherapy improves survival in high- risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [42] Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute
    Lin, Chun-Chi
    Lin, Jen-Kou
    Chang, Shih-Ching
    Wang, Huann-Sheng
    Yang, Shung-Haur
    Jiang, Jeng-Kai
    Chen, Wei-Shone
    Lin, Tzu-Chen
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) : 665 - 676
  • [43] Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute
    Chun-Chi Lin
    Jen-Kou Lin
    Shih-Ching Chang
    Huann-Sheng Wang
    Shung-Haur Yang
    Jeng-Kai Jiang
    Wei-Shone Chen
    Tzu-Chen Lin
    International Journal of Colorectal Disease, 2009, 24 : 665 - 676
  • [44] Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study
    Rosberg, Victoria
    Jessen, Mikkel
    Qvortrup, Camilla
    Smith, Henry George
    Krarup, Peter-Martin
    ACTA ONCOLOGICA, 2023, 62 (09) : 1076 - 1082
  • [45] Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
    Teufel, Andreas
    Gerken, Michael
    Fuerst, Alois
    Ebert, Matthias
    Hohenthanner, Ina
    Klinkhammer-Schalke, Monika
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 148 - 160
  • [46] Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial
    Aoki, Y
    Watanabe, M
    Amikura, T
    Obata, H
    Sekine, M
    Yahata, T
    Fujita, K
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 333 - 339
  • [47] Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study
    Alwers, Elizabeth
    Jansen, Lina
    Blaeker, Hendrik
    Kloor, Matthias
    Tagscherer, Katrin E.
    Roth, Wilfried
    Boakye, Daniel
    Herpel, Esther
    Gruellich, Carsten
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    MOLECULAR ONCOLOGY, 2020, 14 (02) : 363 - 372
  • [48] Outcomes of adjuvant chemotherapy (AC) in young (YP) and elderly patients (EP) with high-risk stage II colon cancer (CC)
    Kumar, Aalok
    Kennecke, Hagen F.
    Lim, Howard John
    Renouf, Daniel John
    Gill, Sharlene
    Woods, Ryan
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Adjuvant chemotherapy (AC) outcomes in young (YP) and elderly patients (EP) with high-risk stage II colon cancer (CC)
    Kumar, Aalok
    Kennecke, Hagen F.
    Lim, Howard John
    Renouf, Daniel John
    Gill, Sharlene
    Woods, Ryan
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study
    Elizabeth, A.
    Jansen, L.
    Hendrik, B.
    Kloor, M.
    Tagscherer, K.
    Roth, W.
    Boakye, D.
    Herpel, E.
    Gruellich, C.
    Chang-Claude, J.
    Brenner, H.
    Hoffmeister, M.
    ANNALS OF ONCOLOGY, 2019, 30
12345